Ani Pharmaceuticals (ANIP) Reports Q4 EPS of $0.35
Ani Pharmaceuticals (NASDAQ: ANIP) reported Q4 EPS of ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
